Edition:
United Kingdom

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

9.05USD
15 Dec 2017
Change (% chg)

$0.90 (+11.04%)
Prev Close
$8.15
Open
$8.15
Day's High
$9.50
Day's Low
$8.15
Volume
1,940,063
Avg. Vol
129,916
52-wk High
$9.50
52-wk Low
$4.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
FY 2015 Dec '15 0.00 -0.177
Sep '15 0.00 -0.162
Jun '15 0.00 -0.141
Mar '15 0.00 -0.141
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Year Ending Dec-17 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 7 -0.33 -0.30 -0.39 -0.23
Quarter Ending Mar-18 5 -0.34 -0.31 -0.39 -0.27
Year Ending Dec-17 7 -1.37 -1.23 -1.45 -0.98
Year Ending Dec-18 7 -1.40 -1.23 -1.58 -1.12
LT Growth Rate (%) 1 -19.00 -19.00 -19.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 4.58 0.85 0.88
Price to Sales (TTM) -- 100.68 5.40
Price to Book (MRQ) 3.81 13.50 5.38
Price to Tangible Book (MRQ) 4.28 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 74.69 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -65.35 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -199.13 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 117.78 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 15.29 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -261.13 15.24
Operating Margin (TTM) -- -556.69 7.76
Operating Margin - 5 Yr. Avg. -- -279.31 10.75
Pre-Tax Margin (TTM) -- -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.05 11.17
Net Profit Margin (TTM) -- -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,316,769 864,680,848
Net Income/Employee (TTM) -1,539,353 3,332,346 101,718,394
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.36 -0.77 11.00
Return on Assets - 5 Yr. Avg. -46.95 -0.26 12.43
Return on Investment (TTM) -49.36 2.36 14.46
Return on Investment - 5 Yr. Avg. -52.23 2.98 16.28
Return on Equity (TTM) -80.46 2.96 16.05
Return on Equity - 5 Yr. Avg. -77.17 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -197.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.17%
# of Holders: 140
Total Shares Held: 60,406,873
3 Mo. Net Change: 7,777,645
# New Positions: 21
# Closed Positions: 17
# Increased Positions: 70
# Reduced Positions: 43
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.